Radio-guided vs clip-guided localization of nonpalpable mass-like lesions of the breast from a screened population : a propensity score-matched study by F. Corsi et al.
 1 
Radio-guided vs. clip-guided localization of non-palpable mass-like lesions of the 
breast from a screened population: a propensity score-matched study 
Fabio Corsia,b*, MD, Daniela Bossib, MD, Francesca Combib, MD, Ourania Papadopoulouc, MD, 
Rosella Amadorid, MD, Lea Regolob, MD, Giuseppe Trifiròe, MD, Sara Albasinib, PhD, Serena 
Mazzucchellia, PhD, Luca Sorrentinoa*, MD 
 
aDepartment of Biomedical and Clinical Sciences “Luigi Sacco”, University of Milan, via G. B. Grassi 74, 20157 Milan, Italy 
bSurgery Department, Breast Unit, ICS Maugeri S.p.A. SB, via Maugeri 10, 27100 Pavia, Italy 
cRadiology Unit, ICS Maugeri S.p.A. SB, via Maugeri 10, 27100 Pavia, Italy 
dBreast Radiology Unit, ICS Maugeri S.p.A. SB, via Clefi 9, 20146 Milan, Italy 
eNuclear Medicine Unit, ICS Maugeri S.p.A. SB, via Maugeri 10, 27100 Pavia, Italy 
 
*Corresponding Authors: 
Prof. Fabio Corsi, MD 
Department of Biomedical and Clinical Sciences “Luigi Sacco”, University of Milan, Via G. B. Grassi, 74, 20157 Milan, Italy 
Surgery Department, Breast Unit, ICS Maugeri S.p.A. SB, via Maugeri 10, 27100 Pavia, Italy 
E-mail: fabio.corsi@unimi.it - Phone: +39.02.5031.9850 - Fax: +39.02.5031.9846 
 
Dr. Luca Sorrentino, MD 
Department of Biomedical and Clinical Sciences “Luigi Sacco”, University of Milan, Via G. B. Grassi, 74, 20157 Milan, Italy 
E-mail: luca.sorrentino1@unimi.it - Phone: +39.02.5031.9850 - Fax: +39.02.5031.9846 
Running head:  Clip vs. ROLL for nonpalpable nodules 
Disclosures and Funding Sources: None. 
 2 
Synopsis for Table of Contents 
Non-palpable breast cancers require an accurate localization for proper lumpectomy. ROLL and ul-
trasound localization of a clip marker are equally effective to reduce involved margins and re-
interventions. ROLL allows more tailored resections for mass-like breast lesions. 
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Abstract 
Background and Objectives: An accurate localization is mandatory to tailor breast lumpectomy in 
non-palpable cancers. The aim of this study was to compare radio-guided localization (ROLL) vs. 
ultrasound localization of a titanium clip with collagen (TCC) in non-palpable mass-like breast can-
cers. 
Methods: 273 consecutive patients were reviewed: 64 patients were localized by TCC and 209 pa-
tients by ROLL. Propensity score-matched analysis was performed. Margins status and re-
intervention rates were compared. Adequacy of resection was expressed as the calculated resection 
ratio (CRR) considering lesion size. Loco-regional and distant recurrence rates were assessed with 
ROLL vs. TCC. 
Results: No differences were found with ROLL vs. TCC in clear margins (90.6% vs. 89.1%, OR 
0.74, p=0.64) or re-operations (6.7% vs. 1.6%, p=0.529). ROLL allowed more tailored resections 
compared to TCC (adjusted CRR 1.7 vs. 2.7, p=0.0008), particularly in lesions with associated ex-
tensive intraductal component (respectively CRR 3.0 vs. 4.5, p=0.017). Loco-regional recurrence 
occurred in 1.9% of ROLL patients vs. 3.2% of TCC cases (p=0.628). 
Conclusions: ROLL and TCC are equally effective to excise non-palpable mass-like breast cancers 
with clear margins, providing similar loco-regional control. However, ROLL allows more tailored 
breast resections, particularly in lesions with associated extensive intraductal component. 
 
 
Keywords: Breast Cancer; Radio-guided Occult Lesion Localization; Clip; Non-palpable breast le-
sions; Breast-conserving surgery 
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Introduction 
Non-palpable breast cancers have increased over time due to the wide adoption of screening mam-
mography and improved patients’ awareness [1-3]. The standard of care for surgical treatment of 
these lesions is breast-conserving surgery [4]. Today the surgeon should perform a tailored resec-
tion to ensure clear margins with smaller resection volumes, in order to associate a reduced risk of 
local relapse with a satisfactory cosmetic outcome [5]. Despite huge advances in breast cancer man-
agement and the recent revolution of the concept of adequate margin, re-interventions still range 
from 20 to 50% [6, 7]. To minimize reoperations rate, an accurate preoperative localization was 
considered mandatory to accurately plan surgery of non-palpable lesions [8]. 
However, yet no localization technique proved to be superior [8, 9]. Comparisons between tech-
niques have been often performed without considering the type of non-palpable lesion, although 
microcalcifications and mass-like lesions could require different localization methods to optimize 
surgery, related to their different clinical features such as visibility on mammography or ultrasound 
(US). Therefore, lesion type may impact the choice of localization technique. We have previously 
described the usefulness of the preoperative localization of a titanium clip embedded with a colla-
gen plug (TCC), positioned after biopsy and visible on US, as a stand-alone technique in non-
palpable breast cancer surgery [10]. 
The aim of the present study was to compare the US localization of TCC vs. US radio-guided occult 
lesion localization (ROLL) in terms of clear margins, re-interventions and resection volumes in 
non-palpable mass-like breast cancers from a screened population. 
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Materials and methods 
Study population and case selection 
From January 2016 to January 2018, 273 consecutive patients affected by non-palpable mass-like 
unifocal breast cancer with clinically negative axillary nodes, diagnosed by screening mammogra-
phy with or without US, and with indication of breast-conserving surgery, were included. All the 
patients were treated at the Breast Unit of ICS Maugeri Hospital, a high-volume tertiary center di-
rectly involved in extensive mammographic screening programs in northern Italy. Mass-like lesions 
included any nodule, mammographic opacity, or parenchymal distortion. Patients affected by mi-
crocalcifications without any associated mass-like lesion, candidated to total mastectomy, or pa-
tients treated by neoadjuvant chemotherapy were excluded from the study. All patients underwent 
breast-conserving surgery with preoperative localization of the lesion. In all cases where the breast 
lesion was almost completely removed by the core biopsy, a TCC (MammoMARK, Devicor Medi-
cal Products, Leica Biosystems, IL, USA) was positioned in the biopsy cavity immediately after the 
procedure. In these cases, preoperative localization was always performed by looking for TCC on 
US. In the remaining case in which the residual lesion after biopsy was clearly visible on US, thus 
excluding the need for a TCC, localization was performed by ROLL under US guidance. 
End-points and outcomes evaluation 
The following outcomes were assessed between TCC and ROLL patients: 
1) Rate of clear margins 
2) Rate of re-interventions 
3) Resection volumes and excess of resected breast tissue 
4) Surgery time 
5) Loco-regional recurrence rate, distant metastases rate and cancer-related death rate 
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Clear margins were defined as no ink on tumor in case of invasive cancer, and 2 mm of free margin 
in case of ductal carcinoma in situ (DCIS) [11, 12]. In case of positive margins, the extent of in-
volvement (focal vs. extensive) and the number of involved margins were reported. After surgery, 
all cases were discussed in the multidisciplinary meeting. The standard approach in case of positive 
margins was a re-operation: specifically, a re-excision of the breast parenchyma surrounding the 
surgical cavity was considered in case of a single margin involvement or multiple focally involved 
margins; in case of extensive involvement of multiple margins, or whether multifocality was ob-
served, a total mastectomy was proposed. However, if a single focally positive margin was ob-
served on final pathology, in selected cases with associated favorable features no further surgery 
was proposed, provided that adjuvant therapy was administered. 
To accurately calculate resection volumes, the three dimensions of surgical specimen and of tumor 
were recorded after surgery. As previously reported, both cancer and specimen were considered as 
ellipsoids [5, 10]. The optimal resection volume (ORV) was defined as the tumor volume plus 1 cm 
of macroscopically clear tissue on all margins, by the following formula: 
 
where a, b and c are the three tumor diameters expressed in cm. The total resection volume (TRV) 
was calculated by the formula: 
 
with d, e and f being the three specimen dimensions. Finally, the calculated resection ratio (CRR) 
expressed the amount of excess of resected breast tissue and thus a parameter to evaluate the ade-
quacy of resection, has been obtained with the formula: 
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Margins status, re-interventions and CRR were also separately analyzed comparing ROLL and TCC 
in lesions with or without extensive intraductal component (EIC), to verify the impact of EIC on 
performance of the two localization techniques. 
Updated follow up data were retrieved by the prospectively-maintained institutional database of the 
Breast Unit. In case of missing follow up, data were obtained from recent outpatient routine clinical 
evaluations, or by phone interview. Loco-regional recurrence was defined as the occurrence of ipsi-
lateral breast cancer or nodal disease proven on core biopsy. Distant metastasis was defined as the 
occurrence of distant lesions with computed tomography and positron emission tomography charac-
teristics highly suggestive of malignancy. Cancer-related death was defined as the breast-cancer 
specific mortality. 
 
Localization techniques and surgery 
In TCC group, patients underwent preoperative localization of the clip with US, being in supine po-
sition with the upper limb abducted, thus resembling the same setting of the operating room. A 
mark was placed on the skin overlying the position of TCC. During surgery, a skin incision fol-
lowed the mark and resection was performed excising breast tissue from skin deep to pectoralis ma-
jor’s fascia [10]. Then, an X-ray on the specimen was obtained to check the removal of the clip, its 
centricity into the specimen, and the macroscopic adequacy of margins. In ROLL group, 15-25 
MBq of 99mTc-labelled human serum albumin nanocolloids (Nanocoll, GEHC, Italy) in 0.2 mL sa-
line were injected into the lesion under US guidance on the day before surgery [13, 14]. The needle 
tip was positioned at the center of the lesion using a linear probe (7.5-10 MHz), and radiotracer was 
then injected. Then, a scintigraphy was performed to assess the adequacy of procedure. During sur-
gery, a gamma probe (Bluetooth Neoprobe Gamma Detection System) was used to localize the le-
sion projection on breast skin, where the incision was made. Resection was then guided by the 
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gamma probe, to repeatedly check the inclusion of the lesion into the specimen. After lesion remov-
al, the gamma probe was used to assess possible residual signal in the resection cavity. In all cases, 
the sentinel lymph node was detected with the radioisotope technique. All the procedures were per-
formed by the same surgical equipe. 
Statistical analysis 
For all patients clinical and pathological variables were collected in a prospectively-maintained da-
tabase. Differences between TCC and ROLL patients were assessed to verify the heterogeneity of 
the study population. Due to the non-random design of the study and the patient selection in assign-
ing localization technique, a propensity score-matched analysis was performed, matching patients 
according to preoperative variables. TCC and ROLL patients were matched in a 1:1 ratio and com-
pared with a logistic regression model adjusted for post-operative variables significantly associated 
with the outcomes, to avoid any bias. Variables were reported as means ± standard deviations or as 
absolute numbers and percentages. Categorical variables were compared using χ2 test or Fisher ex-
act test (two-tailed), while continuous variables were compared using Student’s T test. Bartlett’s 
test for homogeneity of variances was performed on mean CRRs with ROLL vs. TCC. Statistical 
significance was set at p<0.05. Data analysis was performed using STATA software (v. 13, 
StataCorp, Austin, USA). 
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Results 
Variables distribution between TCC and ROLL 
Sixty-four (23.4%) patients underwent localization by TCC, while the remaining 209 patients 
(76.6%) were localized by ROLL. Baseline characteristics of TCC and ROLL patients are reported 
in Table 1. A BI-RADS score 5 was observed in 18.8% of TCC patients and 40.2% of ROLL cases 
(p=0.005). Lesions localized by TCC were more frequently associated to grade 1 compared to 
ROLL group (40.6% vs. 20.1%, p=0.001). A slight increase in axillary dissections was observed 
among ROLL patients compared to TCC cases (14.4% vs. 4.7%, p=0.047). All the other variables 
were balanced between the two groups. 
Margin status, re-intervention rates and operative times 
Negative margins were observed in 90.9% of ROLL patients and in 89.1% of TCC patients (OR 
1.19, 95%CI 0.38-3.75, p=0.77, Table 2). No differences in type of margin involvement or number 
of involved margins were found between ROLL and TCC, although a non-significant increase in 
multiple involved margins was observed with ROLL (31.6% vs. 0% with TCC, p=0.146). A re-
intervention was performed in 6.7% of ROLL patients vs. 1.6% in TCC cases (p=0.529). Eleven pa-
tients with positive margins on final pathology (5 ROLL patients and 6 TCC patients) did not un-
dergo re-excision. Operative time was similar between TCC and ROLL (respectively 65 ±14.2 min 
vs. 62.9 ±27.8 min, p=0.562). No complications related to the localization technique occurred in 
both groups. 
 
Resection volumes and adequacy of resections 
A significantly lower mean resection volume was found with ROLL compared to TCC (43.9 ±37.2 
cm3 vs. 56.8 ±44.1 cm3, p=0.021). Accordingly, mean CRR was lower with ROLL compared to 
TCC, being respectively 2.8 (±2.3) vs. 3.7 (±3.4), p=0.016. 
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Performances of ROLL vs. TCC in lesions with or without associated extensive intraductal compo-
nent 
EIC was present in 73 ROLL patients (34.9%) and in 13 TCC patients (20.3%), p=0.031. Among 
patients with lesion-associated EIC, clear margins were obtained in 82.2% of ROLL patients vs. 
92.3% of TCC cases (p=0.684). No differences were observed in total resection volumes (p=0.534) 
or re-interventions (p=0.815). However, mean CRR was significantly lower in ROLL patients (3.0 
±2.1 vs. 4.5 ±1.6, p=0.017). No significant differences were observed between ROLL and TCC in 
patients without associated EIC. All these data are reported in Table 3. 
 
Adjuvant treatments and oncologic outcomes 
Radiotherapy was proposed in 91.4% of ROLL patients vs. 85.9% of TCC cases (p=0.231). No dif-
ferences were observed also in administration of hormone therapy (respectively in 85.6% vs. 
82.8%, p=0.555) or chemotherapy (8.1% vs. 6.2%, p=0.791), as reported in Table 1. Mean follow 
up was 14.7 ±8.8 months in ROLL group and 16.6 ±8.7 months in TCC group (p=0.131). Loco-
regional recurrence occurred in 1.9% of ROLL patients and in 3.2% of TCC cases (p=0.628). Dis-
tant metastases (p=0.138) and cancer-related death (p=1.000) rates were similar between ROLL and 
TCC patients, as reported in Table 2. 
 
Propensity score-matched analysis and multivariate logistic regression 
After propensity-score matching, no differences were found in margins status with the two localiza-
tion techniques, with ROLL associated to 90.6% negative margins vs. 89.1% with TCC after match-
ing patients (p=0.77). After multivariate analysis, adjusted OR was equal to 0.74 (95%CI 0.21-257, 
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p=0.64). No variable emerged as independently predictive of involved margins. About resection 
volumes, unadjusted mean CRR was 1.8 (±1.1) with ROLL vs. 2.7 (±1.1) with TCC (p=0.003). Af-
ter multivariate analysis, a significantly lower adjusted mean CRR was observed with ROLL com-
pared to TCC (respectively 1.7 vs. 2.7, p=0.0008, Table 4, Figure 1), thus ROLL was independently 
associated to more tailored resections. Notably, CRR was also independently associated to lesion 
size (p=0.003) and presence of DCIS (p=0.02).  Furthermore, CRRs showed a wider variance with a 
higher dispersion using TCC compared to ROLL (p=0.0002, Figure 2).  
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Discussion 
Optimizing the surgical strategy of non-palpable breast lesions by an accurate localization is highly 
required not to lose the benefits of breast-conserving surgery [15]. In this study, ROLL and US lo-
calization of TCC were compared in a large-population study of non-palpable mass-like breast can-
cers.  
Mass-like lesions such as nodules or distortions have been often analyzed together with microcalci-
fications in several previous studies comparing different localization techniques, but these lesions 
do not share the same clinical and pathological features and may differently benefit of available lo-
calization strategies [16-19]. Therefore, type of lesion may affect the choice of localization tech-
nique by surgeons and radiologists: for microcalcifications a stereotactic wire-guided localization 
(WGL) of US localization of TCC might be preferable, while for non-palpable mass-like lesions US 
ROLL could be overwhelmingly used, since nodules are excellently visible on US [20, 21]. Thus, 
analyzing together different types of non-palpable lesions may result in significant biases. Due to 
such concern, we decided to perform a separate analysis for non-palpable mass-like lesions, clear-
ing the study population from microcalcifications to properly compare the two localization tech-
niques. 
In the present study, ROLL and TCC were associated to similar involved margin rates (respectively 
9.1% vs. 10.9%) and similar re-intervention rates (6.7% vs. 1.6%). A discrepancy between involved 
margins and re-intervention rates could be observed, since 11 patients on 26 with involved margins 
were not re-operated. All these patients had only a focal involvement of a single margin and pre-
sented with favourable features (age >50 years, Luminal A lesions, no axillary involvement), there-
fore after discussion of each case in the multidisciplinary meeting of the Breast Unit, a re-excision 
was avoided. 
In 16 patients (5.9%) sentinel lymph node biopsy was not performed, because these patients were 
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affected by pure ductal carcinoma in situ undergoing breast-conserving surgery, therefore axillary 
staging was not routinely recommended [22]. However, the other 13 patients affected by intraductal 
cancer received sentinel node biopsy, due to associated high-risk features predictive of upstaging to 
invasive disease on post-operative histopathology [23]. 
Interestingly, ROLL significantly reduced resected volumes and improved adequacy of resection, 
with an adjusted mean CRR equal to 1.7 vs. 2.7 with TCC (p=0.0008) considering confounder fac-
tors. Interestingly, by analyzing specifically lesions with associated EIC, a significantly higher 
mean CRR emerged with TCC compared to ROLL (4.5 vs. 3.0, p=0.017), while margins status and 
re-interventions were similar. Conversely, no difference was observed between the two techniques 
among lesions without EIC, being mean CRR comparable. In other words, the presence of associat-
ed EIC revealed to have a strong impact on the observed difference in CRR between ROLL and 
TCC. This finding may be related to the lack of an intraoperative guidance during TCC-guided sur-
gery, thus the surgeon may be prone to excise more than needed in treating lesions with associated 
microcalcifications/EIC. Accordingly, lesion size and presence of DCIS emerged as independent 
predictors of higher CRR on multivariate analysis after propensity score matching. Since CRR itself 
normalizes the volume of resection on lesion size, a correlation between higher size and higher 
CRR means that surgeons performed wider excisions if they faced wider lesions or DCIS. Despite 
this tendency and the higher proportion of patients with EIC (34.9% vs. 20.3%, p=0.031), ROLL 
allowed a more tailored surgery compared to TCC, and standardization of surgery thanks to ROLL 
was demonstrated by the lower dispersion of mean CRR (p=0.0002). Indeed, intraoperative guiding 
with ROLL, by continuously checking with the probe the position of the lesion, allowed to tailor the 
resection in real-time, conversely to TCC-guided surgery [24, 25]. 
No difference was observed in oncologic outcomes between ROLL and TCC patients, and in par-
ticular loco-regional recurrences were less frequent among ROLL patients (1.9% vs. 3.2%, 
p=0.628), despite their lower volumes of resection. Thus, TCC-guided surgery was associated to 
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excessive breast resections without a benefit in loco-regional control. Anyway, these findings 
should be cautiously taken into account because follow up was quite short, being no more than 24 
months. HER2-positive and triple-negative breast cancers are associated to early events, but Lu-
minal cancers (the majority of cases in this series) are more frequently late-recurring, thus possible 
recurrences may be missed in the present study [26]. 
No differences were observed in surgery time between ROLL and TCC (respectively 65 vs. 62.9 
minutes) despite operative time included also the intraoperative X-ray of specimen to check the po-
sition of the clip among TCC patients. Notably, presence and position of TCC within the surgical 
specimen was not checked by ex vivo US. TCC-guided surgery only relies on localization of the 
clip without any intraoperative guiding as in case of ROLL. Therefore, to increase the confidence of 
the surgeon to have completely excised the lesion, a further check by looking for the metallic core 
of the clip into the specimen by X-ray was always performed. X-ray unequivocally confirmed the 
presence of the clip within the specimen and allowed the surgeon to check macroscopically for the 
adequacy of margins and the centricity of the TCC. 
Several previous studied compared various localization techniques, demonstrating that ROLL may 
improve localization and excision, with adequate resection volumes, better cosmetic outcome and 
shorter procedure time, but without a consolidated significant difference with other techniques in 
terms of accurate localization [27-33]. A recent meta-analysis endorsed by the Cochrane Collabora-
tion on 11 randomized controlled trials compared the effectiveness of ROLL vs. radioactive seed 
(RSL) and WGL: ROLL and RSL proved to be equivalent to WGL in terms of successful excision, 
although ROLL confirmed to be associated with improved cosmesis [8]. Both WGL and RSL have 
well known drawbacks, such as displacement, fracture or patient’s discomfort in case of WGL, and 
an additional procedure before surgery to insert the seed, as well as radioactivity handling and dis-
posal concerns, in case of RSL [8]. Only a few studies have evaluated US localization of clip mark-
ers, providing encouraging results compared with WGL; however, an accurate assessment of such 
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technique in terms of adequacy of resection volumes specifically in different lesion types is still 
lacking, especially compared with ROLL [34, 35]. 
Most of previous studies were designed before the recent definition of adequate margins for inva-
sive cancer and DCIS, and frequently patients with benign or uncertain lesions were included, con-
versely to the present study [8, 27-33]. Furthermore, adequacy of resection has been often evaluated 
on specimen volumes or weight, or patients’ cosmetic satisfaction, without accurately correlating 
resection volumes with lesion size by CRR. A proper and standardized evaluation of resected vol-
umes should be imperative in this kind of studies, since adequacy of resection is a main end-point 
for breast-conserving surgery of non-palpable cancers, and current imprecisions and heterogeneity 
in volumes measurement have led to inconsistent or controversial results [36, 37]. 
A limitation of the present study is its retrospective and non-random design, which could have po-
tentially affected distribution of baseline variables between groups. However, only BI-RADS and 
grading resulted to be significantly different, and a propensity score matching with multivariate 
analysis was performed to avoid bias. Furthermore, the relatively short follow up could have biased 
the loco-regional recurrence rates between ROLL and TCC patients. 
 
 
Conclusions 
Our findings suggest that ROLL and US localization of TCC are equally effective to excise non-
palpable mass-like breast cancers with clear margins, providing similar loco-regional control, if 
wisely used in a tertiary referral center. However, ROLL is associated to significantly reduced re-
section volumes, allowing to perform more tailored and standardized breast resections particularly 
if extensive intraductal component is present. 
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Tables 
Table 1. Variables distribution between ROLL and TCC groups 
 
ROLL (n = 209) TCC (n = 64) Total (n = 273) p Value 
Age at diagnosis (years) 62.1 (±11.5) 64.2 (±8.4) 62.6 (±10.9) 0.177 
     
BI-RADS     
<4 11 (5.3%) 4 (6.2%) 15 (5.5%) 0.005 
4 114 (54.5%) 48 (75.0%) 162 (59.3%)  
5 84 (40.2%) 12 (18.8%) 96 (35.2%)  
     
Lesion size (mm) 11.3 (±5.5) 10.6 (±5.2) 11.1 (±5.4) 0.368 
     
Histological type     
DCIS 22 (10.5%) 7 (10.9%) 29 (10.6%) 0.711 
Invasive ductal 161 (77.0%) 46 (71.9%) 207 (75.9%)  
Invasive lobular 19 (9.1%) 7 (10.9%) 26 (9.5%)  
Others/No residual lesion 7 (3.3%) 4 (6.3%) 11 (4.0%)  
     
pT stage     
pTis 22 (10.5%) 7 (10.9%) 29 (10.6%) 0.775 
pT1 175 (83.7%) 52 (81.3%) 227 (83.2%)  
pT2 12 (5.8%) 5 (7.8%) 17 (6.2%)  
     
pN stage     
pN0/pNmic 170 (81.3%) 58 (90.6%) 228 (83.5%) 0.876 
pN1 17 (8.1%) 5 (7.8%) 22 (8.0%)  
pN2 7 (3.3%) 0 (0.0%) 7 (2.6%)  
SLNB not performed 15 (7.2%) 1 (1.6%) 16 (5.9%)  
     
Axillary Dissection     
No 179 (85.6%) 61 (95.3%) 240 (87.9%) 0.047 
Yes 30 (14.4%) 3 (4.7%) 33 (12.1%)  
     
Grading     
G1 42 (20.1%) 26 (40.6%) 68 (24.9%) 0.001 
G2 136 (65.1%) 36 (56.3%) 172 (63.0%)  
G3 31 (14.8%) 2 (3.1%) 33 (12.1%)  
     
Biological portrait     
Luminal A 131 (62.7%) 41 (64.1%) 172 (63.0%) 0.419 
Luminal B 55 (26.3%) 20 (31.3%) 75 (27.5%)  
HER2-positive 13 (6.2%) 1 (1.6%) 14 (5.1%)  
TNBC 10 (4.8%) 2 (3.1%) 12 (4.4%)  
     
 22 
Extensive intraductal compo-
nent     
No 136 (65.1%) 51 (79.7%) 187 (68.5%) 0.031 
Yes 73 (34.9%) 13 (20.3%) 86 (31.5%)  
     
Radiotherapy     
No 18 (8.6%) 9 (14.1%) 27 (9.9%) 0.231 
Yes 191 (91.4%) 55 (85.9%) 246 (90.1%)  
     
Hormone therapy     
No 30 (14.4%) 11 (17.2%) 41 (15.0%) 0.555 
Yes 179 (85.6%) 53 (82.8%) 232 (85.0%)  
     
Chemotherapy     
No 192 (91.9%) 60 (93.8%) 252 (92.3%) 0.791 
Yes 17 (8.1%) 4 (6.2%) 21 (7.7%)  
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Table 2. Margins status, re-interventions and oncologic outcomes between ROLL and TCC groups 
 
ROLL 
(n = 209) 
TCC 
(n = 64) 
Total 
(n = 273) 
p Value 
Margin status     
Negative (no ink on tumor) 190 (90.9%) 57 (89.1%) 247 (90.5%) 0.632 
Involved 19 (9.1%) 7 (10.9%) 26 (9.5%)  
     
Type of involved margin     
Focally involved 16 (84.2%) 7 (100.0%) 23 (88.5%) 0.539 
Extensively involved 3 (15.8%) 0 (0.0%) 3 (11.5%)  
     
Number of involved margins     
1 13 (68.4%) 7 (100.0%) 20 (76.9%) 0.146 
>1 6 (31.6%) 0 (0.0%) 6 (23.1%)  
     
Re-intervention     
No 195 (93.3%) 63 (98.4%) 258 (94.5%) 0.529 
Yes: Re-lumpectomy 9 (4.3%) 1 (1.6%) 10 (3.7%)  
Yes: Total mastectomy 5 (2.4%) 0 (0.0%) 5 (1.8%)  
     
Loco-regional recurrence     
No 205 (98.1%) 62 (96.8%) 267 (97.8%) 0.628 
Yes 4 (1.9%) 2 (3.2%) 6 (2.2%)  
     
Distant metastasis     
No 208 (99.5%) 62 (96.8%) 270 (98.9%) 0.138 
Yes 1 (0.5%) 2 (3.2%) 3 (1.1%)  
     
Cancer-related death     
No 209 (100.0%) 64 (100.0%) 273 (100.0%) 1.000 
Yes 0 (0.0%) 0 (0.0%) 0 (0.0%)  
     
Mean follow up (months) 14.7 (±8.8) 16.6 (±8.7) 14.9 (±8.8) 0.131 
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Table 3. Performance of ROLL vs. TCC among lesions with or without associated extensive intra-
ductal component (EIC) 
 
EIC 
(n = 86) 
 
No EIC 
(n = 187) 
 
 ROLL 
(n = 73) 
TCC 
(n = 13) 
p Value 
ROLL 
(n= 136) 
TCC 
(n = 51) 
p Value 
Margin status       
Negative (no ink on tumor) 60 (82.2%) 12 (92.3%) 0.684 130 (95.6%) 45 (88.2%) 0.092 
Involved 13 (17.8%) 1 (7.7%)  6 (4.4%) 6 (11.8%)  
       
Total resection volume (cm3) 46.3 (±34.8) 52.4 (±9.7) 0.534 42.6 (±38.7) 45 (±35.4) 0.699 
       
CRR (mean) 3.0 (±2.1) 4.5 (±1.6) 0.017 2.8 (±2.4) 2.3 (±1.9) 0.183 
       
Re-intervention       
No 64 (87.7%) 13 (100.0%) 0.815 131 (96.3%) 50 (98.0%) 1.000 
Yes: Re-lumpectomy 6 (8.2%) 0 (0.0%)  3 (2.2%) 1 (2.0%)  
Yes: Total mastectomy 3 (4.1%) 0 (0.0%)  2 (1.5%) 0 (0.0%)  
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Table 4. CRR according to localization technique after propensity score 
matched analysis 
 ROLL TCC p Value 
CRR (unadjusted mean) 1.8 (±1.1) 2.7 (±1.1) 0.003 
CRR (adjusted mean) 1.7 (±1.2) 2.7 (±1.2) 0.0008 
Multivariate analysis Estimate/OR 95%CI p Value 
Lesion size -0.04 -0.06-(-0.01) 0.003 
Age at diagnosis 0.007 -0.006-0.02 0.3 
Grading 
   
G1 vs. G3 -0.38 -0.88-0.12 0.14 
G2 vs. G3 -0.27 -0.72-0.18 0.24 
pT stage 
   
DCIS vs. pT2 -0.82 -1.52-(-0.12) 0.02 
pT1 vs. pT2 -0.51 -1.16-0.14 0.12 
BI-RADS 
   
BI-RADS <4 vs. 5 -0.24 -0.81-0.34 0.41 
BI-RADS 4 vs. 5 0.22 -0.13-0.56 0.21 
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Figure Captions 
Fig. 1 Mean adjusted CRRs after breast-conserving surgery between ROLL and TCC in mass-like 
non palpable breast cancers. CRR: calculated resection ratio; ROLL: radio-guided occult lesion lo-
calization; TCC: titanium clip with collagen. 
Fig. 2 Dispersion of CRRs between ROLL and TCC in mass-like non palpable breast cancers. On 
the vertical axis distributions of frequency are reported, while the horizontal axis represents CRRs. 
CRR: calculated resection ratio; ROLL: radio-guided occult lesion localization; TCC: titanium clip 
with collagen. 
 
